Abstract
The national environment in India for the pharmaceutical sector recently underwent changes with The Patents (Amendment)Act 2005, to comply with the TRIPS agreement leading to product patent protection.This has led to Government initiatives to support R&D and promote interlinkages between industry and academia. Globally, innovation ecosystem in recent years has morphed and seen a paradigm shift from a closed innovation in-house R&D model to more open approaches. In this context, the study aspires to gain an understanding of how the institutional and regulatory factors influence adoption of open innovation strategies at firm level and enables formation of innovation networks between universities, public research labs and firms in India.
| Language | English |
|---|---|
| Publication status | Published - 12 Sep 2014 |
| Event | Drug Discovery India 2014 - Ramada Powai Hotel & Convention Centre, Mumbai, India Duration: 11 Sep 2014 → 12 Sep 2014 |
Conference
| Conference | Drug Discovery India 2014 |
|---|---|
| Country | India |
| City | Mumbai |
| Period | 11/09/14 → 12/09/14 |
Fingerprint
Keywords
- innovation
- collaboration
- pharmaceutics
Cite this
}
Open innovation for new drug research in Indian pharmaceutical sector. / Bhatnagar, Bhawani; MacBryde, Jillian; Dörfler, Viktor.
2014. Poster session presented at Drug Discovery India 2014, Mumbai, India.Research output: Contribution to conference › Poster
TY - CONF
T1 - Open innovation for new drug research in Indian pharmaceutical sector
AU - Bhatnagar, Bhawani
AU - MacBryde, Jillian
AU - Dörfler, Viktor
PY - 2014/9/12
Y1 - 2014/9/12
N2 - The national environment in India for the pharmaceutical sector recently underwent changes with The Patents (Amendment)Act 2005, to comply with the TRIPS agreement leading to product patent protection.This has led to Government initiatives to support R&D and promote interlinkages between industry and academia. Globally, innovation ecosystem in recent years has morphed and seen a paradigm shift from a closed innovation in-house R&D model to more open approaches. In this context, the study aspires to gain an understanding of how the institutional and regulatory factors influence adoption of open innovation strategies at firm level and enables formation of innovation networks between universities, public research labs and firms in India.
AB - The national environment in India for the pharmaceutical sector recently underwent changes with The Patents (Amendment)Act 2005, to comply with the TRIPS agreement leading to product patent protection.This has led to Government initiatives to support R&D and promote interlinkages between industry and academia. Globally, innovation ecosystem in recent years has morphed and seen a paradigm shift from a closed innovation in-house R&D model to more open approaches. In this context, the study aspires to gain an understanding of how the institutional and regulatory factors influence adoption of open innovation strategies at firm level and enables formation of innovation networks between universities, public research labs and firms in India.
KW - innovation
KW - collaboration
KW - pharmaceutics
UR - http://selectbiosciences.com/conferences/index.aspx?conf=DDI14
M3 - Poster
ER -